These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 34000622)

  • 1. Clinical features and prognostic factors in Covid-19: A prospective cohort study.
    de Bruin S; Bos LD; van Roon MA; Tuip-de Boer AM; Schuurman AR; Koel-Simmelinck MJA; Bogaard HJ; Tuinman PR; van Agtmael MA; Hamann J; Teunissen CE; Wiersinga WJ; Koos Zwinderman AH; Brouwer MC; van de Beek D; Vlaar APJ;
    EBioMedicine; 2021 May; 67():103378. PubMed ID: 34000622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.
    Bhatraju PK; Morrell ED; Zelnick L; Sathe NA; Chai XY; Sakr SS; Sahi SK; Sader A; Lum DM; Liu T; Koetje N; Garay A; Barnes E; Lawson J; Cromer G; Bray MK; Pipavath S; Kestenbaum BR; Liles WC; Fink SL; West TE; Evans L; Mikacenic C; Wurfel MM
    Crit Care; 2021 Apr; 25(1):148. PubMed ID: 33874973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients.
    Vassiliou AG; Keskinidou C; Jahaj E; Gallos P; Dimopoulou I; Kotanidou A; Orfanos SE
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
    Smadja DM; Guerin CL; Chocron R; Yatim N; Boussier J; Gendron N; Khider L; Hadjadj J; Goudot G; Debuc B; Juvin P; Hauw-Berlemont C; Augy JL; Peron N; Messas E; Planquette B; Sanchez O; Charbit B; Gaussem P; Duffy D; Terrier B; Mirault T; Diehl JL
    Angiogenesis; 2020 Nov; 23(4):611-620. PubMed ID: 32458111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients.
    Spadaro S; Fogagnolo A; Campo G; Zucchetti O; Verri M; Ottaviani I; Tunstall T; Grasso S; Scaramuzzo V; Murgolo F; Marangoni E; Vieceli Dalla Sega F; Fortini F; Pavasini R; Rizzo P; Ferrari R; Papi A; Volta CA; Contoli M
    Crit Care; 2021 Feb; 25(1):74. PubMed ID: 33608030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.
    Guirao JJ; Cabrera CM; Jiménez N; Rincón L; Urra JM
    Mol Immunol; 2020 Dec; 128():64-68. PubMed ID: 33075636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.
    Arnold DT; Attwood M; Barratt S; Morley A; Elvers KT; McKernon J; Donald C; Oates A; Noel A; MacGowan A; Maskell NA; Hamilton FW
    Emerg Med J; 2021 Jul; 38(7):543-548. PubMed ID: 34021028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin.
    Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Vafai-Tabrizi F; Gschwantler M; Fasching P; Wojta J; Giannitsis E; Huber K
    Clin Res Cardiol; 2022 Mar; 111(3):343-354. PubMed ID: 34782921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
    Fernández S; Moreno-Castaño AB; Palomo M; Martinez-Sanchez J; Torramadé-Moix S; Téllez A; Ventosa H; Seguí F; Escolar G; Carreras E; Nicolás JM; Richardson E; García-Bernal D; Carlo-Stella C; Moraleda JM; Richardson PG; Díaz-Ricart M; Castro P
    Shock; 2022 Jan; 57(1):95-105. PubMed ID: 34172614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the admission pattern on the outcome of patients admitted to a respiratory intensive care unit: does a step-down admission differ from a step-up one?
    Valentini I; Pacilli AM; Carbonara P; Fasano L; Vitale R; Zenesini C; Melotti RM; Faenza S; Nava S
    Respir Care; 2013 Dec; 58(12):2053-60. PubMed ID: 23650433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of dying in the ICU: is it worse for patients admitted from the hospital ward compared to those admitted from the emergency department?
    Long AC; Kross EK; Engelberg RA; Downey L; Nielsen EL; Back AL; Curtis JR
    Intensive Care Med; 2014 Nov; 40(11):1688-97. PubMed ID: 25116294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
    Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study.
    Chen Y; Geng Y; Xu X; Chen X; Gao J; Li J; Zhang X
    Ann Palliat Med; 2021 Jan; 10(1):672-680. PubMed ID: 33545796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.
    Phan F; Boussouar S; Lucidarme O; Zarai M; Salem JE; Kachenoura N; Bouazizi K; Charpentier E; Niati Y; Bekkaoui H; Amoura Z; Mathian A; Benveniste O; Cacoub P; Allenbach Y; Saadoun D; Lacorte JM; Fourati S; Laroche S; Hartemann A; Bourron O; Andreelli F; Redheuil A;
    Cardiovasc Diabetol; 2021 Aug; 20(1):165. PubMed ID: 34384426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
    Oulhaj A; Alsuwaidi AR; Suliman A; Gasmelseed H; Khan S; Alawi S; Hukan Y; George J; Alshamsi F; Sheikh F; Babiker ZOE; Prattes J; Sourij H
    Int J Infect Dis; 2021 Jun; 107():188-194. PubMed ID: 33862208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.